bpc-157 lagligt – Research Peptide BPC-157 – Peptide Foundry

The peptides short half-life of 4-6 hours means twice-daily dosing produces more consistent tissue levels than single daily administration

Recommendations on opportunities to reduce the number of animals in genotoxicity tests are published by Pfuhler and colleagues in an ECVAM workshop report (Pfuhler et al., 2009)

Key variables in study design include: Route of Administration: Will the compound be studied via systemic injection (subcutaneous, intramuscular) or a more localized injection near the site of injury

The UPLC and Synapt G2-S systems were operated with MassLynx software (Waters, Manchester), data processing and analysis were performed using MarkerLynx XS TM software